Insulet Corp (PODD)

$142.85 +1.68 (1.19%)
Market Cap 9.79B
Revenue (ttm) 2.71B
Net Income (ttm) 247.10M
EPS (ttm) N/A
PE Ratio 23.73
Forward PE 21.41
Profit Margin 9.12%
Debt to Equity Ratio 0.73
Volume 1,505,000
Avg Vol 1,612,336
Day's Range N/A - N/A
Shares Out 69.35M
Stochastic %K 36%
Beta 1.10
Analysts Sell
Price Target $172.46

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 600 7000
Address:
100 Nagog Park, Acton, United States
bulltrades1234
bulltrades1234 Aug. 10 at 2:00 PM
$PODD let’s get to $150
1 · Reply
MarketPulsee
MarketPulsee Aug. 9 at 10:16 PM
THE WORST-PERFORMING S&P 500 STOCKS THIS YEAR: $TTD -63.7% $CSGP -55.0% $INTU -50.9% $PODD -50.3% $APP -48.5% A stock being down 30–60% doesn’t automatically make it a buy. But it does create a very interesting question: Which companies are facing temporary problems — and which ones have genuinely broken fundamentals? Big drawdowns can create some of the best opportunities when sentiment gets disconnected from long-term business performance. I’m watching the names where valuation, fundamentals, and future growth could start aligning again. Which one would you consider buying after this selloff? Follow my profile for more contrarian ideas, market opportunities, and high-conviction setups before they become obvious. NFA. DYOR.
1 · Reply
crabbypatty31
crabbypatty31 Aug. 9 at 3:26 PM
$PODD Started a small position here on Thursday. Last time I bought this I got stopped out at $165 and the next time I looked it was about double that 😬 Sometimes stop losses are great and other times...
1 · Reply
EquityVoyager_1
EquityVoyager_1 Aug. 8 at 8:23 PM
S&P 500’S BIGGEST LOSERS THIS YEAR - THIS LIST HURTS These are among the hardest-hit S&P 500 names so far this year: $TTD → -63.7% $CSGP → -55.0% $INTU → -50.9% $PODD → -50.3% $APP → -48.5% Massive drawdowns can create opportunity - but they can also signal deeper problems. Which beaten-down name deserves a comeback? Are you going to miss out again? Another alert is coming soon. If notifications are off, chances are you’ll only notice the move once it’s already in progress.
1 · Reply
WallStKoal
WallStKoal Aug. 8 at 8:04 PM
Capitulation Watch: Healthcare Tech & Financial Infrastructure $PODD | YTD -50.3% | Insulin delivery tech leader $BSX | YTD -48.3% | Cardiovascular device giant $ISRG | YTD -33.1% | Robotic surgery platform $FICO | YTD -38.4% | Credit scoring monopoly $COIN | YTD -32.1% | Crypto infrastructure anchor Accumulating dislocated quality requires patience and system. Next execution alert coming soon. Head to my profile to see my full log.
0 · Reply
EquityBlueprint
EquityBlueprint Aug. 8 at 7:52 PM
Capitulation Watch: Healthcare Tech & Financial Infrastructure $PODD | YTD -50.3% | Insulin delivery tech leader $BSX | YTD -48.3% | Cardiovascular device giant $ISRG | YTD -33.1% | Robotic surgery platform $FICO | YTD -38.4% | Credit scoring monopoly $COIN | YTD -32.1% | Crypto infrastructure anchor FIS | YTD -35.7% | Core banking IT infrastructure Accumulating dislocated quality requires patience and system. The next major alert is coming soon. Head to my profile for full updates
0 · Reply
Stocktwits52wLows
Stocktwits52wLows Aug. 7 at 3:16 PM
$PODD printed a new 52-week low today
0 · Reply
bulltrades1234
bulltrades1234 Aug. 7 at 1:43 PM
$PODD hold or sell thoughts
3 · Reply
Knot2
Knot2 Aug. 7 at 1:05 AM
$PODD sell puts?
0 · Reply
Butters33
Butters33 Aug. 6 at 10:15 PM
$PODD - I am a type 1 diabetic who utilizes the Omnipod. I trust PODD with my life so I may as well trust them as an investor. I’m sure many customers are like me who plan to stay on the Omnipod for many years to come. I have been using an insulin pump since the initial pump was invented and no other pump has made such an improvement to my life as the Omnipod. PODD should make it a closed end system by incorporating a CGM on the pump itself. Just my opinion!!
0 · Reply
Latest News on PODD
Insulet price target lowered to $175 from $248 at Baird

2026-08-06T13:38:37.000Z - 4 days ago

Insulet price target lowered to $175 from $248 at Baird

Insulet price target lowered to $180 from $190 at Deutsche Bank

2026-08-06T13:11:25.000Z - 4 days ago

Insulet price target lowered to $180 from $190 at Deutsche Bank

Leerink downgrades Insulet to Market Perform, lowers target to $145

2026-08-06T13:10:52.000Z - 4 days ago

Leerink downgrades Insulet to Market Perform, lowers target to $145

Insulet price target lowered to $144 from $294 at TD Cowen

2026-08-06T12:51:48.000Z - 4 days ago

Insulet price target lowered to $144 from $294 at TD Cowen

Insulet price target lowered to $185 from $250 at Benchmark

2026-08-06T12:44:53.000Z - 4 days ago

Insulet price target lowered to $185 from $250 at Benchmark

Insulet price target lowered to $150 from $174 at UBS

2026-08-06T12:36:43.000Z - 4 days ago

Insulet price target lowered to $150 from $174 at UBS

Insulet price target lowered to $180 from $225 at Stifel

2026-08-06T12:26:46.000Z - 4 days ago

Insulet price target lowered to $180 from $225 at Stifel

Insulet price target lowered to $175 from $200 at Bernstein

2026-08-06T12:11:41.000Z - 4 days ago

Insulet price target lowered to $175 from $200 at Bernstein

Insulet downgraded to Market Perform from Outperform at Leerink

2026-08-06T11:31:38.000Z - 4 days ago

Insulet downgraded to Market Perform from Outperform at Leerink

Insulet price target lowered to $160 from $245 at RBC Capital

2026-08-06T11:13:58.000Z - 4 days ago

Insulet price target lowered to $160 from $245 at RBC Capital

Insulet price target lowered to $179 from $249 at Canaccord

2026-08-06T11:07:35.000Z - 4 days ago

Insulet price target lowered to $179 from $249 at Canaccord

Insulet downgraded to Neutral from Buy at BTIG

2026-08-06T09:50:27.000Z - 4 days ago

Insulet downgraded to Neutral from Buy at BTIG

Insulet downgraded to Neutral from Overweight at JPMorgan

2026-08-06T08:55:28.000Z - 4 days ago

Insulet downgraded to Neutral from Overweight at JPMorgan

Insulet downgraded to Equal Weight from Overweight at Wells Fargo

2026-08-05T22:15:59.000Z - 5 days ago

Insulet downgraded to Equal Weight from Overweight at Wells Fargo

Insulet downgraded to Hold from Buy at Truist

2026-08-05T20:36:46.000Z - 5 days ago

Insulet downgraded to Hold from Buy at Truist

Oppenheimer calls Insulet outlook ‘huge surprise,’ downgrades shares

2026-08-05T18:10:52.000Z - 5 days ago

Oppenheimer calls Insulet outlook ‘huge surprise,’ downgrades shares

Insulet downgraded to Perform from Outperform at Oppenheimer

2026-08-05T18:05:46.000Z - 5 days ago

Insulet downgraded to Perform from Outperform at Oppenheimer

Insulet price target lowered to $150 from $172 at Citi

2026-08-05T17:35:21.000Z - 5 days ago

Insulet price target lowered to $150 from $172 at Citi

This Medtech Beat Earnings Estimates. It's the Worst S&P 500 Stock Today.

Aug 5, 2026, 12:17 PM EDT - 5 days ago

This Medtech Beat Earnings Estimates. It's the Worst S&P 500 Stock Today.

Insulet falls -20.7%

2026-08-05T16:06:15.000Z - 5 days ago

Insulet falls -20.7%

Insulet Slides: Investor presentation

Aug 5, 2026, 9:00 AM EDT - 5 days ago

Insulet Slides: Investor presentation

Insulet cuts sales growth forecast on slower US insulin-pump sales; shares fall

Aug 5, 2026, 8:11 AM EDT - 5 days ago

Insulet cuts sales growth forecast on slower US insulin-pump sales; shares fall

Insulet Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 5 days ago

Insulet Earnings Call Transcript: Q2 2026

Insulet Earnings release: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 5 days ago

Insulet Earnings release: Q2 2026

Insulet Slides: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 5 days ago

Insulet Slides: Q2 2026

Insulet Quarterly report: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 5 days ago

Insulet Quarterly report: Q2 2026

Insulet Reports Second Quarter 2026 Results

Aug 5, 2026, 7:00 AM EDT - 5 days ago

Insulet Reports Second Quarter 2026 Results

PODD INVESTOR REMINDER: Insulet Corporation Investors Have Until August 31, 2026 To Seek Lead Plaintiff Role

Aug 4, 2026, 7:00 PM EDT - 6 days ago

PODD INVESTOR REMINDER: Insulet Corporation Investors Have Until August 31, 2026 To Seek Lead Plaintiff Role

$PODD Fraud Notification: Insulet Sued for Fraud Over Misrepresentations about its Safety Issues – Investors Notified to Contact BFA Law

Jul 24, 2026, 6:36 AM EDT - 17 days ago

$PODD Fraud Notification: Insulet Sued for Fraud Over Misrepresentations about its Safety Issues – Investors Notified to Contact BFA Law

Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

Jul 14, 2026, 3:00 AM EDT - 27 days ago

Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

PODD Investors Have Rights - If You Lost Money Investing in Insulet Corporation Contact Robbins LLP for Information About Recovering Your Losses

Jul 13, 2026, 5:14 PM EDT - 4 weeks ago

PODD Investors Have Rights - If You Lost Money Investing in Insulet Corporation Contact Robbins LLP for Information About Recovering Your Losses

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD

Jul 9, 2026, 1:32 PM EDT - 4 weeks ago

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD

INSULET CORPORATION (PODD) INVESTOR ALERT Investors With Large Losses in Insulet Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jul 6, 2026, 12:04 PM EDT - 5 weeks ago

INSULET CORPORATION (PODD) INVESTOR ALERT Investors With Large Losses in Insulet Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Insulet Slides: Investor presentation

Jul 6, 2026, 7:00 AM EDT - 5 weeks ago

Insulet Slides: Investor presentation

Grabar Law Office Investigates Claims on Behalf of Shareholders of Insulet Corporation (PODD)

Jul 3, 2026, 1:31 PM EDT - 5 weeks ago

Grabar Law Office Investigates Claims on Behalf of Shareholders of Insulet Corporation (PODD)

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

Jul 1, 2026, 7:00 AM EDT - 5 weeks ago

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

20 stocks in the S&P 500 that plunged the most in 2026's first half

Jun 30, 2026, 7:55 AM EDT - 5 weeks ago

20 stocks in the S&P 500 that plunged the most in 2026's first half

ACN ADBE BR BSX CRM CSGP CTSH

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

Jun 25, 2026, 7:00 AM EDT - 6 weeks ago

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Jun 4, 2026, 7:00 AM EDT - 2 months ago

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Insulet Transcript: 46th Annual William Blair Growth Stock Conference

Jun 3, 2026, 3:00 PM EDT - 2 months ago

Insulet Transcript: 46th Annual William Blair Growth Stock Conference

Insulet Slides: 46th Annual William Blair Growth Stock Conference

Jun 3, 2026, 3:00 PM EDT - 2 months ago

Insulet Slides: 46th Annual William Blair Growth Stock Conference

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor

Jun 3, 2026, 7:00 AM EDT - 2 months ago

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor

US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

May 28, 2026, 10:34 AM EDT - 2 months ago

US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

May 27, 2026, 4:05 PM EDT - 2 months ago

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost

May 26, 2026, 4:50 PM EDT - 2 months ago

Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

May 26, 2026, 4:05 PM EDT - 2 months ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rally

May 20, 2026, 10:05 AM EDT - 2 months ago

These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rally

APH APP AXON CSGP CVNA EL FICO

Insulet Transcript: AGM 2026

May 20, 2026, 8:00 AM EDT - 2 months ago

Insulet Transcript: AGM 2026

Insulet Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 12:20 PM EDT - 3 months ago

Insulet Transcript: Bank of America Global Healthcare Conference 2026

Insulet Slides: FY 2026

May 13, 2026, 12:20 PM EDT - 3 months ago

Insulet Slides: FY 2026

Insulet Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Earnings Call Transcript: Q1 2026

Insulet Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Earnings release: Q1 2026

Insulet Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Slides: Q1 2026

Insulet Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Quarterly report: Q1 2026

Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand

May 6, 2026, 7:46 AM EDT - 3 months ago

Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand

Insulet Reports First Quarter 2026 Results

May 6, 2026, 7:00 AM EDT - 3 months ago

Insulet Reports First Quarter 2026 Results

Insulet Slides: Investor presentation

May 6, 2026, 7:00 AM EDT - 3 months ago

Insulet Slides: Investor presentation

Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities

May 5, 2026, 7:00 AM EDT - 3 months ago

Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities

Insulet Slides: Omnipod® 5 competitive clinical performance presentation

May 5, 2026, 7:00 AM EDT - 3 months ago

Insulet Slides: Omnipod® 5 competitive clinical performance presentation

Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes

May 4, 2026, 7:00 AM EDT - 3 months ago

Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes

Insulet to Participate in BofA Securities 2026 Health Care Conference

Apr 28, 2026, 7:00 AM EDT - 3 months ago

Insulet to Participate in BofA Securities 2026 Health Care Conference

Insulet Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Insulet Proxy statement: Proxy filing

Insulet Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Insulet Proxy statement: Proxy filing

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Apr 1, 2026, 7:00 AM EDT - 4 months ago

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Insulet Appoints Mike Panos as Chief Commercial Officer

Mar 30, 2026, 8:30 AM EDT - 4 months ago

Insulet Appoints Mike Panos as Chief Commercial Officer

Insulet recalls some insulin devices in US over leakage risk

Mar 12, 2026, 5:22 PM EDT - 5 months ago

Insulet recalls some insulin devices in US over leakage risk

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

Mar 12, 2026, 4:05 PM EDT - 5 months ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Mar 11, 2026, 4:01 PM EDT - 5 months ago

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Mar 10, 2026, 7:00 AM EDT - 5 months ago

Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Insulet Earnings Call Transcript: Q4 2025

Feb 18, 2026, 8:00 AM EST - 6 months ago

Insulet Earnings Call Transcript: Q4 2025

Insulet Annual report: Q4 2025

Feb 18, 2026, 8:00 AM EST - 6 months ago

Insulet Annual report: Q4 2025

Insulet Earnings release: Q4 2025

Feb 18, 2026, 8:00 AM EST - 6 months ago

Insulet Earnings release: Q4 2025

Insulet Slides: Q4 2025

Feb 18, 2026, 8:00 AM EST - 6 months ago

Insulet Slides: Q4 2025

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Feb 18, 2026, 7:55 AM EST - 6 months ago

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Insulet Reports Fourth Quarter and Full Year 2025 Results

Feb 18, 2026, 7:00 AM EST - 6 months ago

Insulet Reports Fourth Quarter and Full Year 2025 Results

Insulet Slides: Investor presentation

Feb 18, 2026, 7:00 AM EST - 6 months ago

Insulet Slides: Investor presentation

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

Feb 5, 2026, 7:00 AM EST - 6 months ago

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

Is PODD A Better Bet Than ISRG Stock?

Jan 19, 2026, 12:41 PM EST - 7 months ago

Is PODD A Better Bet Than ISRG Stock?

ISRG

Insulet Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 7 months ago

Insulet Transcript: 44th Annual J.P. Morgan Healthcare Conference

Insulet Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 7 months ago

Insulet Slides: 44th Annual J.P. Morgan Healthcare Conference

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

Jan 9, 2026, 6:00 AM EST - 7 months ago

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

Jan 6, 2026, 7:00 AM EST - 7 months ago

Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 7:00 AM EST - 8 months ago

Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

Dec 15, 2025, 7:00 AM EST - 8 months ago

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

bulltrades1234
bulltrades1234 Aug. 10 at 2:00 PM
$PODD let’s get to $150
1 · Reply
MarketPulsee
MarketPulsee Aug. 9 at 10:16 PM
THE WORST-PERFORMING S&P 500 STOCKS THIS YEAR: $TTD -63.7% $CSGP -55.0% $INTU -50.9% $PODD -50.3% $APP -48.5% A stock being down 30–60% doesn’t automatically make it a buy. But it does create a very interesting question: Which companies are facing temporary problems — and which ones have genuinely broken fundamentals? Big drawdowns can create some of the best opportunities when sentiment gets disconnected from long-term business performance. I’m watching the names where valuation, fundamentals, and future growth could start aligning again. Which one would you consider buying after this selloff? Follow my profile for more contrarian ideas, market opportunities, and high-conviction setups before they become obvious. NFA. DYOR.
1 · Reply
crabbypatty31
crabbypatty31 Aug. 9 at 3:26 PM
$PODD Started a small position here on Thursday. Last time I bought this I got stopped out at $165 and the next time I looked it was about double that 😬 Sometimes stop losses are great and other times...
1 · Reply
EquityVoyager_1
EquityVoyager_1 Aug. 8 at 8:23 PM
S&P 500’S BIGGEST LOSERS THIS YEAR - THIS LIST HURTS These are among the hardest-hit S&P 500 names so far this year: $TTD → -63.7% $CSGP → -55.0% $INTU → -50.9% $PODD → -50.3% $APP → -48.5% Massive drawdowns can create opportunity - but they can also signal deeper problems. Which beaten-down name deserves a comeback? Are you going to miss out again? Another alert is coming soon. If notifications are off, chances are you’ll only notice the move once it’s already in progress.
1 · Reply
WallStKoal
WallStKoal Aug. 8 at 8:04 PM
Capitulation Watch: Healthcare Tech & Financial Infrastructure $PODD | YTD -50.3% | Insulin delivery tech leader $BSX | YTD -48.3% | Cardiovascular device giant $ISRG | YTD -33.1% | Robotic surgery platform $FICO | YTD -38.4% | Credit scoring monopoly $COIN | YTD -32.1% | Crypto infrastructure anchor Accumulating dislocated quality requires patience and system. Next execution alert coming soon. Head to my profile to see my full log.
0 · Reply
EquityBlueprint
EquityBlueprint Aug. 8 at 7:52 PM
Capitulation Watch: Healthcare Tech & Financial Infrastructure $PODD | YTD -50.3% | Insulin delivery tech leader $BSX | YTD -48.3% | Cardiovascular device giant $ISRG | YTD -33.1% | Robotic surgery platform $FICO | YTD -38.4% | Credit scoring monopoly $COIN | YTD -32.1% | Crypto infrastructure anchor FIS | YTD -35.7% | Core banking IT infrastructure Accumulating dislocated quality requires patience and system. The next major alert is coming soon. Head to my profile for full updates
0 · Reply
Stocktwits52wLows
Stocktwits52wLows Aug. 7 at 3:16 PM
$PODD printed a new 52-week low today
0 · Reply
bulltrades1234
bulltrades1234 Aug. 7 at 1:43 PM
$PODD hold or sell thoughts
3 · Reply
Knot2
Knot2 Aug. 7 at 1:05 AM
$PODD sell puts?
0 · Reply
Butters33
Butters33 Aug. 6 at 10:15 PM
$PODD - I am a type 1 diabetic who utilizes the Omnipod. I trust PODD with my life so I may as well trust them as an investor. I’m sure many customers are like me who plan to stay on the Omnipod for many years to come. I have been using an insulin pump since the initial pump was invented and no other pump has made such an improvement to my life as the Omnipod. PODD should make it a closed end system by incorporating a CGM on the pump itself. Just my opinion!!
0 · Reply
mexmanTV
mexmanTV Aug. 6 at 9:41 PM
$PODD
0 · Reply
NorthstarT1D
NorthstarT1D Aug. 6 at 2:06 PM
$PODD these analysts are laughable. They lowered 2026 guidance by 1%, analysts are cutting targets by 30-50%
1 · Reply
anachartanalyst
anachartanalyst Aug. 6 at 12:02 PM
$PODD https://anachart.com/wp-content/uploads/2026/08/1786017722_soc-img.jpg
0 · Reply
anachartanalyst
anachartanalyst Aug. 6 at 11:02 AM
$PODD https://anachart.com/wp-content/uploads/2026/08/1786014138_soc-img.jpg
0 · Reply
anachartanalyst
anachartanalyst Aug. 6 at 10:02 AM
$PODD https://anachart.com/wp-content/uploads/2026/08/1786010540_soc-img.jpg
0 · Reply
bulltrades1234
bulltrades1234 Aug. 6 at 3:50 AM
$PODD a little bounce back tomorrow
0 · Reply
deepthinker
deepthinker Aug. 5 at 9:25 PM
$PODD Too many competitors in this space. Consolidation needed. Which will go first? Tandem can’t be sold because Dexcom holds rights.
0 · Reply
SahreIn
SahreIn Aug. 5 at 9:16 PM
$PODD damn these analysts have downgraded it so bad already . But add few shares on a daily basis … same happened with alnylam and we see up already by 20 dollars
0 · Reply
Thedgbman
Thedgbman Aug. 5 at 8:14 PM
$PODD wouldnt be shocked if it rallies rest of week and gets back to $170
1 · Reply
anvesti
anvesti Aug. 5 at 7:52 PM
Anvesti closed a long position $PODD 🔴 -9.89% $148.08 → $133.44 Model: ml_model_v1 · Score: 81.2 Reason: Stop Loss · 57 days
0 · Reply
NorthstarT1D
NorthstarT1D Aug. 5 at 7:32 PM
$PODD rarely seen a company go down 20%+ on a double beat quarter 😅
0 · Reply
investingisswag
investingisswag Aug. 5 at 6:53 PM
$PODD EVERYONE IS OVERREACTING
0 · Reply